A Study of TAK-861 in Participants With Narcolepsy Type 1

Clinical trial NCT05687903 · COMPLETED

Trial details

NCT number: NCT05687903
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Narcolepsy Type 1

Start date: 2023-01-09
Primary completion: 2023-12-14
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.